BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1638838)

  • 1. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors.
    Caluser C; Macapinlac H; Healey J; Ghavimi F; Meyers P; Wollner N; Kalaigian J; Kostakoglu L; Abdel-Dayem HM; Yeh SD
    Clin Nucl Med; 1992 Jul; 17(7):565-72. PubMed ID: 1638838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
    Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
    Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
    Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
    Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [201Tl scintigraphic evaluation of tumor mass and viability of bone and soft-tissue tumors].
    Tsuda T; Kubota M; Yoshida S; Shibata M; Wakabayashi J; Obata H; Matsuyama T; Usui M; Ishii S
    Kaku Igaku; 1994 Dec; 31(12):1477-94. PubMed ID: 7861647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.
    Caluser CI; Abdel-Dayem HM; Macapinlac HA; Scott A; Healey JH; Huvos A; Kalaigian H; Yeh SD; Larson SM
    Eur J Nucl Med; 1994 Nov; 21(11):1198-205. PubMed ID: 7859771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thallium-201 uptake and Tc-99m red blood cell accumulation in hemangioma.
    Verdú J; Martínez A; Antón MA; Muñoz JM; Riera M; Jover R; Caballero O
    Clin Nucl Med; 2005 Jan; 30(1):25-6. PubMed ID: 15604963
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors.
    Nishiyama Y; Yamamoto Y; Yokoe K; Kawaguchi Y; Toyama Y; Satoh K; Ohkawa M
    Ann Nucl Med; 2004 May; 18(3):235-41. PubMed ID: 15233285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (99m)Tc-MDP uptake in soft-tissue osteosarcoma in a dog.
    Lass P; Krzemiński M; Teodorczyk J
    Nucl Med Rev Cent East Eur; 2004; 7(2):189. PubMed ID: 15968610
    [No Abstract]   [Full Text] [Related]  

  • 9. Tl-201 and Tc-99m HMDP scintigraphic findings in extraskeletal osteosarcoma.
    Kajihara M; Sugawara Y; Miki H; Mochizuki T; Kidani T; Sakayama K
    Clin Nucl Med; 2005 May; 30(5):356-8. PubMed ID: 15827415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tl-201 uptake in bone and soft tissue involvement of sarcoidosis.
    Degirmenci B; Mavi A; Ozkal S; Itil O; Havitcioglu H; Ozaksoy D; Yilmaz M; Kaya GC
    Clin Nucl Med; 2001 Jun; 26(6):499-501. PubMed ID: 11353294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tl-201 uptake in brown tumors of hyperparathyroidism.
    Durak H; Aras T; Sungur C; Erbengi G; Bekdik CF
    Clin Nucl Med; 1991 Dec; 16(12):931-5. PubMed ID: 1769175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
    Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
    Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.
    Ramanna L; Waxman A; Binney G; Waxman S; Mirra J; Rosen G
    J Nucl Med; 1990 May; 31(5):567-72. PubMed ID: 2341892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nuclear medicine in primary bone and soft tissue tumors.
    Abdel-Dayem HM
    Semin Nucl Med; 1997 Oct; 27(4):355-63. PubMed ID: 9364645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
    J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better visualization of retinoblastoma metastases with Tc-99m sestamibi versus Tl-201.
    Aktolun C; Bayhan H; Ozturk E
    Clin Nucl Med; 1995 May; 20(5):446-8. PubMed ID: 7628151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tl-201 uptake in recurrent pigmented villonodular synovitis. Correlation with three-phase bone imaging.
    Caluser C; Healey J; Macapinlac H; Kostakoglu L; Abdel-Dayem HM; Larson SM; Yeh SD
    Clin Nucl Med; 1992 Sep; 17(9):751-3. PubMed ID: 1395357
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual Concentration of Tc-99m methylendiphosphonate in Rhabdomyosarcoma.
    Franco A; Henderson PR; McDonough CH
    J Radiol Case Rep; 2012 Sep; 6(9):29-34. PubMed ID: 23378886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
    Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
    Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.